New guidelines on thromboembolism prophylaxes - Implications for our specialty;Die neue S3-Leitlinie zur Thromboembolieprophylaxe - Bedeutung fur unser Fachgebiet

Anasthesiologie und Intensivmedizin

Volumn 50, Issue 5, 2009, Pages 316-323

  Gogarten, W ^a   Van Aken, H ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Aspirin; Coronary artery stents; Heparin induced thrombocytopenia; Neuraxial blockade; Thromboembolism prophylaxis; Timing

Indexed keywords

ACETYLSALICYLIC ACID; DABIGATRAN; FONDAPARINUX; HEPARIN; RIVAROXABAN;

ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY STENT; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MEDICAL SPECIALIST; NEUROSURGERY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PROSTATECTOMY; REGIONAL ANESTHESIA; THROMBOCYTOPENIA; THROMBOEMBOLISM; TONSILLECTOMY; UNITED STATES;

EID: 67149113679     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hull RD, Pineo GF, Maclsaac S. Low-molecular-weight heparin prophylaxis: preoperative versus postoperative initiation in patients undergoing elective hip surgery. Thromb Res 2000;101:V155-V162.
2. Strebel N, Prins M, Agnelli G, Büller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery. Arch Intern Med 2002;162:1451-1456.
3. Sanderink GJ, Guimart CG, Ozoux ML, Jariwala NU, Shukla UA, Boutouyrie BX. Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment. Thromb Res 2002;105:225-231.
4. Dickinson LD, Miller LD, Patel CP, Gupta SK. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 1998;43:1074- 1081.
5. Colwell CWJ, Kwong LM, Turpie AG, Davidson BL. Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery. J Arthroplasty 2006;21:36-45.
6. Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:340S-380S.
7. Warkentin TE, Cook RJ, Marder VJ, et ai. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood 2005;106:3791-3796.
8. Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. New Engl J Med 2007;356:2653-2655.
9. Lobo B, Finch C, Howard A, Minhas S. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia. Thromb Haemost 2008;99:208-214.
10. Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 2001;161:1268-1279.
11. Limpus A, Chaboyer W, McDonald E, Thalib L. Mechanical thromboprophylaxis in critically ill patients: a systematic review and meta-analysis. Am J Crit Care 2006;15:402-410.
12. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
13. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:381 S-453S.
14. Hilbert P, Teumer P, Stuttmann R. Thrombembolieprophylaxe auf deutschen Intensivstationen. Ergebnisse einer bundesweiten Umfrage. Anaesthesist 2008;57:242-250.
15. Priglinger U, Delle Karth G, Geppert A, et al. Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill? Crit Care Med 2003;31:1405-1409.
16. Dorffler-Melly J, de Jonge E, de Pont AC, et al. Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet 2002;359:849-850.
17. Jochberger S, Mayr V, Luckner G, et al. Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study. Crit Care2005;9:R541-8.
18. Lim W, Dentali F, Eikelboom JW, Crowther MA. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 2006;144:673-684.
19. Christie IW, McCabe S. Major complications of epidural analgesia after surgery: results of a six-year survey. Anaesthesia 2007;62:335-341.
20. Popping DM, Zahn PK, Van Aken HK, Dasch B, Boche R, Pogatzki-Zahn EM. Effectiveness and safety of postoperative pain management: a survey of 18 925 consecutive patients between 1998 and 2006 (2nd revision): a database analysis of prospectively raised data. Br J Anaesth 2008;101:832-840.
21. Cook TM, Counsell D, Wildsmith JA. Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth 2009;102:179- 190.
22. Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994;79:1165-1177.
23. Gogarten W. The influence of new antithrombotic drugs on regional anesthesia. Curr Opin Anaesthesiol 2006;19:545-550.
24. Lee LA, Posner KL, Domino KB, Caplan RA, Cheney FW. Injuries associated with regional anesthesia in the 1980s and 1990s. A closed claims analysis. Anesthesiology 2004;101:143- 152.
25. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 2004;101:950-959.
26. Gogarten W, Van Aken H, Buttner J, Riess H, Wulf H, Buerkle H. Ruckenmarksnahe Regionalanasthesien und Throm- boembolieprophylaxe/ antithrombotische Medikation. 2. iiberar- beitete Empfehlungen der Deutschen Gesellschaft fur Anasthesiologie und Intensivmedizin. Anaesth Intensivmed 2007;48:S109-S124.
27. Patrono C, Baigent C, Hirsh J, Roth G, Hirsh J, Roth G. Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:199-233.
28. Burger W, Chemnitius JM, Kneissl GD, Riicker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioprative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005; 257:399-414.
29. Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal A special risk for late stent thrombosis. J Am Coll Cardiol 2005;45:456-459.
30. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008;109:596-604.
31. Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007;115:813-818.
32. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 2008;106:685-712.
33. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:299S-339S.
34. Becker RC, Meade TW, Berger PB, et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:776S-814S.
35. th Edition). Chest 2008;133:815S-843S.